Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc (AYTU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aytu BioPharma Announces Formation of New Scientific Advisory Board to Support Development of AR101 for Vascular Ehlers-Danlos Syndrome

Chaired by Dr. Hal Dietz and joined initially by Dr. Xavier Jeunemaitre, Dr. Shaine Morris, Dr. Bart Loeys, and Dr. Peter Byers with additional advisors to be added

AYTU : 3.13 (+3.30%)
SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc., Eargo, Inc., and Corcept Therapeutics, Inc. ...

ODT : 3.00 (-6.54%)
AYTU : 3.13 (+3.30%)
EAR : 21.97 (+0.92%)
CORT : 20.51 (-0.58%)
Aytu BioPharma to Present at Upcoming September Investor Conferences

ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced...

AYTU : 3.13 (+3.30%)
AYTU : 3.13 (+3.30%)
Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus

ENGLEWOOD, CO / ACCESSWIRE / July 27, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced...

AYTU : 3.13 (+3.30%)
Implied Volatility Surging for Aytu Biopharma (AYTU) Stock Options

Investors need to pay close attention to Aytu Biopharma (AYTU) stock based on the movements in the options market lately.

AYTU : 3.13 (+3.30%)
Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study

Results Indicate That Endotracheal UVA Light Catheter Therapy is Associated with Significant Reduction in SARS-CoV-2 Viral Load and Improvement in Clinical Outcomes in Mechanically Ventilated COVID-19...

AYTU : 3.13 (+3.30%)
Thinking about buying stock in Anavex Life Sciences, Globalstar, Rapt Therapeutics, Aytu Biopharma, or Evofem Biosciences?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXL, GSAT, RAPT, AYTU, and EVFM.

GSAT : 1.7700 (-1.12%)
EVFM : 0.8377 (+3.04%)
RAPT : 39.47 (+1.65%)
AVXL : 17.63 (+3.89%)
AYTU : 3.13 (+3.30%)
Aytu BioPharma to Present at Upcoming June Investor Conferences

ENGLEWOOD, CO / ACCESSWIRE / May 25, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced...

AYTU : 3.13 (+3.30%)
Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights

NEOS : 1.1500 (-2.54%)
AYTU : 3.13 (+3.30%)
Aytu Biopharma, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Aytu Biopharma, Inc. (NASDAQ:AYTU) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 17, 2021 at 4:30 PM Eastern...

AYTU : 3.13 (+3.30%)

Barchart Exclusives

Natural Gas- Higher Multi-Year Highs
Natural gas has been making higher lows over the past fifteen months. The energy commodity began making higher multi-year highs in June 2021. With the peak season for demand on the horizon, the price is trading above $5, a level not seen since February 2014. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar